Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08ILW
|
|||
| Former ID |
DNC014089
|
|||
| Drug Name |
Cyclohexyl biphenyl-4-ylcarbamate
|
|||
| Synonyms |
cyclohexyl biphenyl-4-ylcarbamate; CHEMBL541244; SCHEMBL12166742; URB602, 3k
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H21NO2
|
|||
| Canonical SMILES |
C1CCC(CC1)OC(=O)NC2=CC=C(C=C2)C3=CC=CC=C3
|
|||
| InChI |
1S/C19H21NO2/c21-19(22-18-9-5-2-6-10-18)20-17-13-11-16(12-14-17)15-7-3-1-4-8-15/h1,3-4,7-8,11-14,18H,2,5-6,9-10H2,(H,20,21)
|
|||
| InChIKey |
SSVRRVRYQFRADL-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors. Eur J Med Chem. 2009 Jul;44(7):2994-3008. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.